APA (7th ed.) Citation

Khrieba, M. O., Abdulelah, F. M., Badawoud, A. M., Hamza, E., Al-Dhelaan, R. A., Ahmed, T. I., . . . Kamal, M. (2026). Adjunctive Pentoxifylline Enhances Clinical Remission and Reduces Inflammatory Biomarkers in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-Controlled Pilot Trial. Pharmaceuticals (14248247), 19(4), 552. https://doi.org/10.3390/ph19040552

Chicago Style (17th ed.) Citation

Khrieba, Mohannad O., et al. "Adjunctive Pentoxifylline Enhances Clinical Remission and Reduces Inflammatory Biomarkers in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-Controlled Pilot Trial." Pharmaceuticals (14248247) 19, no. 4 (2026): 552. https://doi.org/10.3390/ph19040552.

MLA (9th ed.) Citation

Khrieba, Mohannad O., et al. "Adjunctive Pentoxifylline Enhances Clinical Remission and Reduces Inflammatory Biomarkers in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-Controlled Pilot Trial." Pharmaceuticals (14248247), vol. 19, no. 4, 2026, p. 552, https://doi.org/10.3390/ph19040552.